Monthly Archives: October 2011

DNA Patenting “Urban Legend” Debunked At AIPLA

Posted on October 21, 2011 by Warren Woessner

The  most interesting presentation at the Annual AIPLA Meeting – which is not yet over – was Professor Christopher M. Holman’s talk – “Deconstructing the myth that 20% of  the human genome is patented” which was based on his paper … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , | Leave a comment

EU High Court Bans Patents on Cells Requiring Processing Human Embryos

Posted on October 18, 2011 by Warren Woessner

Defining “human embryos” broadly, The Court of Justice of the European Union has ruled that pluripotent stem cells derived from human embryos and totipotent stem cells derived from blastocysts are not patentable if they are obtained by destroying human embryos … Continue reading →

Posted in Stem Cells/Cloning | Tagged , , , , | 1 Comment

Infringement by Unobvious Changes – A Look (Way) Back

Posted on October 16, 2011 by Warren Woessner

As a much younger attorney, I gave a presentation at the 1990 AIPLA Annual Meeting:  “A Review of Recent Federal Circuit Decisions Relating to Infringement” (AIPLA Selected Legal Papers, 9, 3 (July 1991)), in which I wrestled with the question … Continue reading →

Posted in Doctrine of Equivalents, Infringement | Tagged , , , , , , , , , , , , | Leave a comment

Obviousness = Equivalence? Saint-Gobain v. Siemens

Posted on October 14, 2011 by Warren Woessner

Saint-Gobain Ceramics (“S-G”) has asked the Supreme Court to review the Fed. Cir. panel below, 647 F.3d 1373 (Fed. Cir. 2011) in which the panel decision refused to reverse a district court decision that instructed the jury that it could … Continue reading →

Posted in Doctrine of Equivalents | Tagged , , , , , , , , , , , , , , | 1 Comment